Drug Approvals & Discovery Watch
Global and Indian news on new drug approvals, regulatory decisions, clinical milestones, drug candidates, discovery platforms and emerging therapies.
Bitter pills: on Court’s intervention, drug pricing - The Hindu
Bitter pills: on Court’s intervention, drug pricing The Hindu…
Aurobindo’s arm, Acrotech Biopharma, launches Adquey in US - BusinessLine
Aurobindo’s arm, Acrotech Biopharma, launches Adquey in US BusinessLine…
Realty, pharma: Investors tap into domestic-economy focused sectors in H1 - Business Standard
Realty, pharma: Investors tap into domestic-economy focused sectors in H1 Business Standard…
Stocks to Watch Today: Aurobindo Pharma, Highway Infra, NCC, Blue Dart, Symbiotec Pharma, Shadowfax,... - Moneycontrol.com
Stocks to Watch Today: Aurobindo Pharma, Highway Infra, NCC, Blue Dart, Symbiotec Pharma, Shadowfax,... Moneycontrol.com…
Punjab will be ‘chitta-mukt (drug-free)’ by December 31, 2029: Amit Shah - The Indian Express
Punjab will be ‘chitta-mukt (drug-free)’ by December 31, 2029: Amit Shah The Indian Express…
Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial - Reuters
Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial Reuters…
Regulator fails timely fitness-to-practise standard for eighth year running - pharmaceutical-journal.com
Regulator fails timely fitness-to-practise standard for eighth year running pharmaceutical-journal.com…
Developing better pancreatic clinical trials - BioWorld News
Developing better pancreatic clinical trials BioWorld News…
FDA seeks scientists and consumer representatives for advisory panels - Reuters
FDA seeks scientists and consumer representatives for advisory panels Reuters…
HHS announces new efforts to speed up, expand clinical trials with AI - STAT
HHS announces new efforts to speed up, expand clinical trials with AI STAT…
Prime editing of human hematopoietic stem cells for correction of GATA2 deficiency - Science | AAAS
Prime editing of human hematopoietic stem cells for correction of GATA2 deficiency Science | AAAS…
Speech clocks decode dementia phenotypes, social exposome, and biological aging - Science | AAAS
Speech clocks decode dementia phenotypes, social exposome, and biological aging Science | AAAS…
Pharma dept to offer gap funding for early-stage novel drug discovery - Business Standard
Pharma dept to offer gap funding for early-stage novel drug discovery Business Standard…
Drug discovery in Q3 2026 – what changed and why it matters - Drug Target Review
Drug discovery in Q3 2026 – what changed and why it matters Drug Target Review…
Intravenous hyaluronidase-expressing oncolytic adenovirus with chemotherapy in metastatic pancreatic cancer: a randomized phase 2b trial - nature.com
Intravenous hyaluronidase-expressing oncolytic adenovirus with chemotherapy in metastatic pancreatic cancer: a randomized phase 2b trial nature.com…
AbbVie’s eczema drug shows benefit in Phase 2; BioMarin lays off 117 - Endpoints News
AbbVie’s eczema drug shows benefit in Phase 2; BioMarin lays off 117 Endpoints News…
Hansoh’s Tagrisso rival loses EU approval after AstraZeneca legal challenge - Fierce Pharma
Hansoh’s Tagrisso rival loses EU approval after AstraZeneca legal challenge Fierce Pharma…
CSPC’s herpes zoster vaccine SYS-6052 gains IND approval - BioWorld News
CSPC’s herpes zoster vaccine SYS-6052 gains IND approval BioWorld News…
BioNTech Shuts Germany, Singapore Sites as COVID Vaccine Production Winds Down - Medical Dialogues
BioNTech Shuts Germany, Singapore Sites as COVID Vaccine Production Winds Down Medical Dialogues…
Stock markets fall for 3rd day; Sensex drops 48 pts on fag-end selling in metal, pharma shares - bfsi.economictimes.indiatimes.com
Stock markets fall for 3rd day; Sensex drops 48 pts on fag-end selling in metal, pharma shares bfsi.economictimes.indiatimes.com…
‘Lasting victory is when youngsters never start drugs’: Haryana anti-drug body CEO - The Indian Express
‘Lasting victory is when youngsters never start drugs’: Haryana anti-drug body CEO The Indian Express…
'Someone who gets intoxicated': Amit Shah takes dig at AAP, vows drug-free Punjab by 2029 - The Times of India
'Someone who gets intoxicated': Amit Shah takes dig at AAP, vows drug-free Punjab by 2029 The Times of India…
Drug patents in India: How they work and when govt can override them - Business Standard
Drug patents in India: How they work and when govt can override them Business Standard…
Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's Aurora Facility - Business Standard
Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's Aurora Facility Business Standard…
₹3,000 cr drug haul busted: Indian Coast Guard intercepts Iranian dhow, 5 Pakistanis held - The Economic Times
₹3,000 cr drug haul busted: Indian Coast Guard intercepts Iranian dhow, 5 Pakistanis held The Economic Times…
AstraZeneca enters strategic equity investment and clinical collaboration with Summit Therapeutics to advance leading ADC combination strategy in cancer - Pharmabiz.com
AstraZeneca enters strategic equity investment and clinical collaboration with Summit Therapeutics to advance leading ADC combination strategy in cancer Pharmabiz.com…
Iranians face soaring medicine prices as US blockade, sanctions hit hard - Business Standard
Iranians face soaring medicine prices as US blockade, sanctions hit hard Business Standard…
GST appellate authority upholds ₹4.6 crore ITC claim order against Aurobindo Pharma - BusinessLine
GST appellate authority upholds ₹4.6 crore ITC claim order against Aurobindo Pharma BusinessLine…
In a first, government admits in SC problem of exorbitant pricing of drugs, promises fix - The Times of India
In a first, government admits in SC problem of exorbitant pricing of drugs, promises fix The Times of India…
Supporting biosimilar development could unlock "massive demand", says trade body - pharmaceutical-journal.com
Supporting biosimilar development could unlock "massive demand", says trade body pharmaceutical-journal.com…
Fake medicine racket: SIT arrests another accused in Bengaluru - The Times of India
Fake medicine racket: SIT arrests another accused in Bengaluru The Times of India…
UniQure tumbles with latest data for Huntington’s gene therapy - BioPharma Dive
UniQure tumbles with latest data for Huntington’s gene therapy BioPharma Dive…
'This is carnage': SC flags high drug prices, moots 16% margin cap - Business Standard
'This is carnage': SC flags high drug prices, moots 16% margin cap Business Standard…
UniQure crashes as Huntington’s gene therapy shows less slowing of disease at 4 years - BioSpace
UniQure crashes as Huntington’s gene therapy shows less slowing of disease at 4 years BioSpace…
AstraZeneca Invests $2B in Summit Therapeutics, Inks Clinical Trial Collab - Genome Web
AstraZeneca Invests $2B in Summit Therapeutics, Inks Clinical Trial Collab Genome Web…
Lilly touts Foundayo advantage over Novo's Ozempic pill in diabetes analysis - Reuters
Lilly touts Foundayo advantage over Novo's Ozempic pill in diabetes analysis Reuters…
US exempts select Indian specialty drugs from 100% tariff - BusinessLine
US exempts select Indian specialty drugs from 100% tariff BusinessLine…
Fake Mounjaro to unapproved retatrutide: Inside India's booming weight-loss drug black market - livemint.com
Fake Mounjaro to unapproved retatrutide: Inside India's booming weight-loss drug black market livemint.com…
CSPC allowed to advance mRNA cancer vaccine SYS-6077 into clinic in China - BioWorld News
CSPC allowed to advance mRNA cancer vaccine SYS-6077 into clinic in China BioWorld News…
CCTV is no cure for weak drug regulation - The Indian Express
CCTV is no cure for weak drug regulation The Indian Express…
SIT arrests seventh accused in fake medicine racket; Chennai link under scanner - The Hindu
SIT arrests seventh accused in fake medicine racket; Chennai link under scanner The Hindu…
BJP’s 4,000 km anti-drug yatra to end with Amit Shah’s Jalandhar show tomorrow - The Indian Express
BJP’s 4,000 km anti-drug yatra to end with Amit Shah’s Jalandhar show tomorrow The Indian Express…
Rare diseases can be treated with tailored gene therapy but India’s regulatory system must evolve - livemint.com
Rare diseases can be treated with tailored gene therapy but India’s regulatory system must evolve livemint.com…
Kodiak’s stock rallies on Phase III wAMD success - Clinical Trials Arena
Kodiak’s stock rallies on Phase III wAMD success Clinical Trials Arena…
Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial - National Institutes of Health (NIH) | (.gov)
Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial National Institutes of Health (NIH) | (.gov)…
US waives 100% tariff on select Indian speciality drugs – Which ones are exempt? - financialexpress.com
US waives 100% tariff on select Indian speciality drugs – Which ones are exempt? financialexpress.com…
Nifty Pharma defies mkt slump, up 1% as select drugs exempt from US tariffs - Business Standard
Nifty Pharma defies mkt slump, up 1% as select drugs exempt from US tariffs Business Standard…
US waives 100% tariff on select Indian speciality drugs - The Indian Express
US waives 100% tariff on select Indian speciality drugs The Indian Express…
Why rare-disease drugs could become India’s next pharma frontier - The Hindu
Why rare-disease drugs could become India’s next pharma frontier The Hindu…
Trump's 100% pharma tariff kicks in today, select Indian drugs get relief - Business Standard
Trump's 100% pharma tariff kicks in today, select Indian drugs get relief Business Standard…
Egetis Therapeutics’ Emcitate cleared by FDA for rare X-linked genetic disease - Endpoints News
Egetis Therapeutics’ Emcitate cleared by FDA for rare X-linked genetic disease Endpoints News…
FDA Approves First Treatment for MCT8 Deficiency - fda.gov
FDA Approves First Treatment for MCT8 Deficiency fda.gov…
Roche’s Gazyva secures FDA nod for idiopathic nephrotic syndrome, extending autoimmune pivot - Fierce Pharma
Roche’s Gazyva secures FDA nod for idiopathic nephrotic syndrome, extending autoimmune pivot Fierce Pharma…
Pills, needles, loopholes: Cops battle prescription drug abuse in Chennai - The Times of India
Pills, needles, loopholes: Cops battle prescription drug abuse in Chennai The Times of India…
Non-invasive control of gene editing in vivo by photoswitchable Cas12f and focused ultrasound - Cell Press
Non-invasive control of gene editing in vivo by photoswitchable Cas12f and focused ultrasound Cell Press…
India, 19 other countries get US tariff relief on certain speciality drugs - Moneycontrol.com
India, 19 other countries get US tariff relief on certain speciality drugs Moneycontrol.com…
Merck inks up to $2.13B deal to dine with SciBrunch, gain rights to preclinical KRAS inhibitor - BioSpace
Merck inks up to $2.13B deal to dine with SciBrunch, gain rights to preclinical KRAS inhibitor BioSpace…
Punjab's election drug debate has old players in new roles: BJP, Congress attack as AAP defends its record - The Times of India
Punjab's election drug debate has old players in new roles: BJP, Congress attack as AAP defends its record The Times of India…
AbbVie's Cerevel buyout delivers as FDA gives go-ahead to 1st-in-class Juvmo in Parkinson's disease - Fierce Pharma
AbbVie's Cerevel buyout delivers as FDA gives go-ahead to 1st-in-class Juvmo in Parkinson's disease Fierce Pharma…
Merck, Daiichi Sankyo retract accelerated approval request for lung cancer ADC - BioSpace
Merck, Daiichi Sankyo retract accelerated approval request for lung cancer ADC BioSpace…
Fake drug racket suspect who fled to Azerbaijan held on arrival in Bengaluru - The Indian Express
Fake drug racket suspect who fled to Azerbaijan held on arrival in Bengaluru The Indian Express…
Tiziana Life Sciences Announces First Participants Dosed in ALS BANYAN Clinical Trial of Intranasal Foralumab - Financial Times
Tiziana Life Sciences Announces First Participants Dosed in ALS BANYAN Clinical Trial of Intranasal Foralumab Financial Times…
Spurious drugs racket kingpin arrested in Bengaluru - The Hindu
Spurious drugs racket kingpin arrested in Bengaluru The Hindu…
Sun Pharma bags rights to $3.7 billion cholesterol drug market globally - Business Standard
Sun Pharma bags rights to $3.7 billion cholesterol drug market globally Business Standard…
Karnataka flags drug landing cost-MRP gap at hospitals of up to 52.6 times; seeks Centre's intervention - The Times of India
Karnataka flags drug landing cost-MRP gap at hospitals of up to 52.6 times; seeks Centre's intervention The Times of India…
Cancer, kidney, AIDS drugs sold at up to 70 times procurement cost: Karnataka Minister - The Hindu
Cancer, kidney, AIDS drugs sold at up to 70 times procurement cost: Karnataka Minister The Hindu…
‘We were a junior alliance partner’: Dhillon rejects AAP’s charge on drug menace during 2007-2017 - The Indian Express
‘We were a junior alliance partner’: Dhillon rejects AAP’s charge on drug menace during 2007-2017 The Indian Express…
Molecular profiling is changing cancer treatment in India: Dr Raman Narang - Pharmabiz.com
Molecular profiling is changing cancer treatment in India: Dr Raman Narang Pharmabiz.com…
US FDA approves Mirum's drug for rare bone disorder - Reuters
US FDA approves Mirum's drug for rare bone disorder Reuters…
MedWatch: FDA Safety Information & Adverse Event Reporting Program - fda.gov
MedWatch: FDA Safety Information & Adverse Event Reporting Program fda.gov…